Australia-based Mayne Pharma ($MYX) has been expanding its manufacturing in the U.S. to build up capacity in the world’s richest market. Now it will expand in…

With its $14 billion buyout of Merck's consumer health unit two years ago, Bayer Healthcare picked up Coppertone sunscreen products. Bayer now has hit a…

Sandoz restarted production at a sterile injectables plant in Canada late Sunday night and said it will soon lift a temporary allocation system after working…

The kingpin behind a scheme that sold $17 million worth of foreign-made cancer meds and other drugs--claiming that they were FDA approved--in the U.S. is going…

As some Big Pharma players have struggled in China recently, AstraZeneca has managed to keep up its double-digit sales growth there through the first quarter.…

The FDA has found serious enough problems at a Teva sterile injectables plant in Hungary that it has banned most of its products from the U.S., leading Teva to…

Merck & Co. is facing another supply interruption for its ovulation-stimulating hormone Follistim, and like the supply lapse from several years ago, Merck…

Akorn and its Hi-Tech Pharmacal unit have had a number of recalls lately involving its liquid products, including more than 7,200 bottles of dental mouth rinse…

AstraZeneca has received a CRL tied to manufacturing issues that are delaying the potential approval of the drug candidate for which it ponied up $2.7 billion…